Retinal Dystrophies Clinical Trial
Official title:
iPS Cells of Patients for Models of Retinal Dystrophies
The investigators are focused on inherited retinal dystrophies with an aim to further understand disease pathophysiology and to elaborate novel treatments, as, to date, there is no effective treatment to prevent blindness. The main goal of this study is to generate human cellular models of healthy and disease retinas and perform studies to evaluate the efficiency of gene therapy approaches for different diseases. Skin biopsies of volunteers are cultured to isolate fibroblasts that are then reprogrammed into iPS cells. Healthy and disease-specific iPS cells are then differentiated into retinal models. This study should help to elucidate disease pathways and to provide proof-of-concept for various therapeutic approaches.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04123626 -
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
|
Phase 1/Phase 2 | |
| Completed |
NCT01546181 -
Retinal Imaging by Adaptive Optics in Healthy Eyes and During Retinal and General Diseases
|
||
| Recruiting |
NCT03592017 -
Performance of Long-wavelength Autofluorescence Imaging
|
N/A | |
| Recruiting |
NCT04855045 -
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06177977 -
SS-HH-OCT as a Novel Diagnostic Modality for Early-Onset Retinal Dystrophies (EORDs)
|
N/A | |
| Completed |
NCT02983305 -
Optical Head-Mounted Display Technology for Low Vision Rehabilitation
|
N/A | |
| Recruiting |
NCT05573984 -
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
|
||
| Completed |
NCT03763227 -
Intravitreal Ranibizumab (Lucentis®) in the Treatment of Non-leaking Macular Cysts in Retinal Dystrophy
|
Phase 2 | |
| Completed |
NCT04945772 -
Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
|
Phase 2 | |
| Recruiting |
NCT05294978 -
EyeConic: Qualification for Cone-Optogenetics
|
||
| Recruiting |
NCT05218928 -
Qualification for Cone-Optogenetics
|
||
| Completed |
NCT03843840 -
Dual Wavelength OCT
|
||
| Enrolling by invitation |
NCT06162585 -
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
|
||
| Recruiting |
NCT02014389 -
Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer
|
||
| Not yet recruiting |
NCT06319872 -
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
|
Phase 1 |